(S)-3-Fluoropyrrolidine hydrochloride, 98.0%, 250mg

4-Bromo-2-fluoroanisole>98.0%(GC)5g

8-oxoadenosine, 98%, 250mg

2',5'-Dimethyl-[1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid, 98%, 5g

Carbonate de baryum, min 99 %, pa, ACS, 500 g, emballage plastique.

1-Methyl-2-(propan-2-yl)-1h-1,3-benzodiazole, 97%, 250mg

(4S,5S)-1,3-Bis(2-(methoxymethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 250mg

2-(3-Hydroxypropyl)benzimidazole, 97.0%, 10g

(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine hydrochloride, 500mg

(R)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine>98.0%(GC)1g

(R)-4-(1-Aminoethyl)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide dihydrochloride, 95.0%, 1g

8-Fluoroquinazoline-2,4(1H,3H)-dione, 95.0%, 250mg

N-(3-Aminopropyl)diethanolamine>90.0%(GC)500g